IDEAYA Announces Achievement of First Milestone in Ongoing Collaboration with GSK for Potential First-in-Class Pol Theta Helicase Inhibitor Development Candidate
Stock Information for IDEAYA Biosciences Inc.
Loading
Please wait while we load your information from QuoteMedia.